基于纳米技术的安全有效的免疫治疗策略
Seeun Hong1, Juwon Park1, Yoojeong Oh1
1Graduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University, Seoul 03760, Republic of Korea.
Molecules (Basel, Switzerland)
|January 8, 2025
概括
纳米粒子可以通过诱导免疫细胞死亡 (ICD) 来增强癌症免疫疗法. 本综述探讨了纳米粒子与化疗,辐射,光动力学和光热疗法的结合,以改善固体瘤中抗癌免疫反应.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 材料科学 材料科学 材料科学
背景情况:
- 癌症免疫疗法,特别是免疫检查点封锁,显示出希望,但在固体瘤中扎着低响应率.
- 瘤微环境 (TME) 通常具有免疫抑制作用,阻碍有效的抗癌免疫反应.
- 需要制定战略,将TME转化为免疫激活状态,以提高免疫治疗的疗效.
研究的目的:
- 审查使用纳米粒子最大限度地提高免疫细胞死亡 (ICD) 诱导的策略.
- 要突出各种治疗方式与基于纳米粒子的免疫疗法的整合.
- 为未来纳米粒子辅助癌症免疫疗法研究提供见解.
主要方法:
- 对纳米粒子介导癌症治疗现有文献的综述.
- 对将纳米粒子与化疗,辐射疗法 (RT),光动力疗法 (PDT) 和光热疗法 (PTT) 结合的研究进行分析.
- 专注于诱导瘤微环境中的免疫细胞死亡 (ICD) 的策略.
主要成果:
- 纳米粒子为增强ICD诱导提供了一个多功能平台.
- 将纳米颗粒与化疗,RT,PDT或PTT结合起来,可以有效地重塑免疫抑制性TME.
- 这些结合的方法显示了提高癌症免疫疗法的疗效的潜力.
结论:
- 基于纳米粒子的策略对于克服癌症免疫疗法的挑战至关重要.
- 通过联合疗法最大限度地诱导ICD是一种激活抗瘤免疫力的关键方法.
- 对纳米粒子辅助免疫疗法的进一步研究对治疗固体瘤具有重大前景.
相关概念视频
Tumor Immunotherapy
472
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
472
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cytotoxic T Cells-mediated Immune Response
841
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
841
Cancer Vaccines
337
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
337


